Mbx Biosciences Inc
(MBX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 68,194 | 35,311 | 25,161 |
| Operating Income | -68,194 | -35,311 | -25,161 |
| Interest Expense | 0 | 0 | 374 |
| Other Income | 6,272 | 2,748 | -600 |
| Pre-tax Income | -61,922 | -32,563 | -26,135 |
| Net Income Continuous | -61,922 | -32,563 | -26,135 |
| Net Income | $-61,922 | $-32,563 | $-26,135 |
| EPS Basic Total Ops | -5.82 | -31.96 | -39.18 |
| EPS Basic Continuous Ops | -5.82 | -31.96 | -39.18 |
| EPS Diluted Total Ops | -5.82 | -31.96 | -39.18 |
| EPS Diluted Continuous Ops | -5.82 | -31.96 | -39.18 |
| EPS Diluted Before Non-Recurring Items | -5.82 | N/A | N/A |
| EBITDA(a) | $-67,950 | $-35,154 | $-25,105 |